Senvest Management’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,693
Closed -$4.02M 51
2018
Q3
$4.02M Hold
6,693
0.3% 33
2018
Q2
$5.02M Hold
6,693
0.35% 41
2018
Q1
$5.17M Hold
6,693
0.39% 38
2017
Q4
$5.12M Buy
6,693
+743
+12% +$575K 0.36% 42
2017
Q3
$5.01M Buy
5,950
+1,191
+25% +$997K 0.33% 45
2017
Q2
$4.28M Buy
4,759
+1,535
+48% +$1.3M 0.34% 48
2017
Q1
$2.88M Buy
3,224
+147
+5% +$138K 0.21% 48
2016
Q4
$3.19M Sell
3,077
-1,035
-25% -$1.07M 0.23% 47
2016
Q3
$8.15M Hold
4,112
0.58% 37
2016
Q2
$7M Hold
4,112
0.57% 38
2016
Q1
$7.19M Buy
4,112
+133
+3% +$212K 0.6% 36
2015
Q4
$7.02M Buy
3,979
+133
+3% +$235K 0.53% 38
2015
Q3
$6.6M Buy
3,846
+190
+5% +$459K 0.48% 43
2015
Q2
$9.9M Buy
3,656
+3,061
+514% +$7.95M 0.62% 41
2015
Q1
$1.72M Buy
595
+153
+35% +$424K 0.11% 75
2014
Q4
$1.16M Buy
+442
New +$1.14M 0.08% 63

Other funds holding TRIB

Senvest Management's TRIB Position: Q4 2018 in Review

Senvest Management sold out of Trinity Biotech (TRIB) in Q4 2018, closing a stake of 6,693 shares — an estimated $4.02M sold.

Senvest Management first reported a position in TRIB in Q4 2014 and held it in 16 quarters. The position peaked at $9.9M in Q2 2015. 40 funds tracked by Wall St. Rank hold TRIB as of Q4 2018.

  • Senvest Management reported no remaining Trinity Biotech position as of Q4 2018 after selling out during the quarter.
  • Senvest Management sold 6,693 Trinity Biotech shares in Q4 2018, an estimated $4.02M.
  • Senvest Management first reported a position in Trinity Biotech in Q4 2014 and held it in 16 quarters.
  • Senvest Management's Trinity Biotech position peaked at $9.9M in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2018.

Based on Senvest Management's 13F filing for Q4 2018, filed 14 Feb 2019.